Stephanie Patton et al v. Forest Laboratories, LLC

Filing 137

FINAL JUDGMENT AS TO ALL CLAIMS AND PARTIES by Judge Michael W. Fitzgerald. IT IS HEREBY ORDERED, ADJUDGED AND DECREED that judgment be entered as follows: (1) Judgment on all claims is entered in favor of all Defendants and Plaintiffs shall take nothing by their Second Amended Complaint. (2) Defendants are awarded their costs as provided by law. (MD JS-6, Case Terminated). (iv)

1
2

JS-6

3
4
5
6
7
8

UNITED STATES DISTRICT COURT

9

FOR THE CENTRAL DISTRICT OF CALIFORNIA

10
11
12

STEPHANIE PATTON, KENDRICK
KNIGHTEN, and THE ESTATE OF
KENNADI KNIGHTEN,

13
14
15
16
17
18

Case No. EDCV-17-922-MWF (PLAx)
FINAL JUDGMENT AS TO ALL
CLAIMS AND PARTIES

Plaintiffs,
vs.
FOREST LABORATORIES, INC.;
FOREST PHARMACEUTICALS,
INC.; ALLERGAN, INC.; and
ALLERGAN SALES, LLC,
Defendants.

19
20
21
22
23
24
25

This action was timely removed to this Court on May 11, 2017. All claims
have now been resolved against all parties, as follows:
Plaintiffs’ original Complaint asserted claims against Defendants Allergan,

26

plc; Allergan, Inc.; Forest Laboratories, Inc.; Actavis, plc (“Actavis”); Lupin

27

Pharmaceuticals, Inc. (“Lupin”); Cipla Ltd. and Cipla USA, Inc. (collectively, the

28

“Cipla Defendants”); Teva Pharmaceuticals USA, Inc. (“Teva”); CVS Pharmacy,
1

1

Inc.; Target Corporation (“Target”); and the Riverside County Regional Medical

2

Center (“RCRMC”).

3

On July 6, 2017, Defendants Actavis and Allergan, plc, and all claims

4

against them, were dismissed pursuant to the parties’ Stipulation of Voluntary

5

Dismissal of Foreign Corporate Defendants. (Docket No. 18).

6

On January 29, 2018, Plaintiffs filed their First Amended Complaint,

7

asserting claims against Defendants Forest Laboratories, Inc. and Forest

8

Pharmaceuticals, Inc. (together “Forest”); Allergan, Inc.; Lupin; the Cipla

9

Defendants; Teva; CVS Health Corporation and CVS Pharmacy, Inc. (together

10

“CVS”); Target; the County of Riverside (the “County”); and RCRMC. (Docket

11

No. 85).

12

On February 2, 2018, the Cipla Defendants, and all claims against them,

13

were dismissed by the Court’s Order re Stipulation of Dismissal with Prejudice of

14

Defendants Cipla Ltd. and Cipla USA, Inc. (Docket Nos. 86-87).

15
16

On May 10, 2018, Defendants Lupin, Teva, the County, RCRMC, CVS, and
Target, and all claims against them, were dismissed as follows:

17

 Lupin, Teva, the County, and RCRMC by the Court’s Order re Joint Motion

18

of Defendants Lupin Pharmaceuticals, Inc. and Teva Pharmaceuticals USA,

19

Inc. to Strike and Dismiss Plaintiffs’ Amended Complaint; and

20

 CVS and Target by the Court’s Order re CVS Pharmacy, Inc. and Target

21

Corporation’s Motion to Dismiss All Claims Against CVS Pharmacy, Inc.

22

and Target Corporation.

23
24

(Docket No. 115).
On July 9, 2018, Plaintiffs filed their Second Amended Complaint, asserting

25

claims against only Defendants Forest; Allergan, Inc.; and Allergan Sales, LLC

26

(collectively, the “Allergan Defendants”). (Docket No. 124). Defendant Forest

27

merged into Allergan Sales, LLC, which took over the defense of Forest.

28
2

1

On September 19, 2018, the Allergan Defendants, and all claims against

2

them, were dismissed by the Court’s Order re Allergan Sales, LLC, and Allergan,

3

Inc.’s Motion to Dismiss Plaintiffs’ Second Amended Complaint for Damages.

4

(Docket No. 136).

5

Now, therefore, pursuant to Rules 54 and 58 of the Federal Rules of Civil

6

Procedure, IT IS HEREBY ORDERED, ADJUDGED AND DECREED that

7

judgment be entered as follows:

8

1.

9
10

Judgment on all claims is entered in favor of all Defendants and
Plaintiffs shall take nothing by their Second Amended Complaint.

2.

Defendants are awarded their costs as provided by law.

11
12
13
14
15

Dated: September 19, 2018

______________________________
MICHAEL W. FITZGERALD
United States District Judge

16
17
18
19
20
21
22
23
24
25
26
27
28
3